Doctor profile · Federal record

Dr. Erfon Ekhlasi, MD

Dermatology Physician (CMS: Dermatology) · Dermatology Physician · Dermatology Physician · Dermatology Physician · Bradenton, FL

  • NPI 1013366582
  • Accepts Medicare
  • MIPS 81.3 / 100 · 2023
  • 9 yrs in practice
  • Licensed in 4 states
  • Male
  • Group practice
  • No sanctions

Practice & contact

Operates at 6 locations .

NPPES Updated May 11, 2026
Primary practice
300 Riverside Dr E Ste 2200
Bradenton, FL 342081023
(941) 748-3376
fax (941) 748-7562
Additional location
123 C Ave
Lake Oswego, OR 970342353
(503) 905-9006
Additional location
37587 Highway 26
Sandy, OR 970559301
(503) 506-0474
Show 3 more locations
Additional location
966 12Th St Se Ste 130
Salem, OR 973022860
(503) 837-6395
Additional location
5901 Steilacoom Blvd Sw
Tacoma, WA 984993120
(253) 363-9199
Additional location
9951 Mickelberry RD Nw Ste 201
Silverdale, WA 983838309
(360) 692-1814

Credentials & registration

NPPES · NUCC
NPI registered
June 2016 — 10 yrs on file
Profile last updated
February 13, 2026
Year of graduation
2017 — 9 yrs since
Specialty taxonomy
207N00000X — NUCC code
State licenses (4)
Florida #ME133728 · Massachusetts #293390 · Oregon #MD223732 · Washington #MD.MD.61643734

Federal sanctions & exclusions

OIG LEIE Updated May 11, 2026

No sanctions, exclusions or revocations on file

Checked against OIG LEIE on NPI 1013366582. Last verified May 11, 2026.

Medicare procedures · 2023

Top services delivered

CMS Provider Utilization
Total services
1,754
Distinct HCPCS
10
Medicare allowed
$108,222
HCPCS Description Services Patients Avg allowed
17003 Destruction of precancer skin growth, 2-14 growths 615 118 $6
99203 New patient office or other outpatient visit, 30-44 minutes 208 208 $110
17000 Destruction of precancer skin growth, 1 growth 184 159 $49
11102 Biopsy of related skin growth, first growth 106 94 $82
99204 New patient office or other outpatient visit, 45-59 minutes 73 73 $164
17003 Destruction of precancer skin growth, 2-14 growths 70 14 $2
17110 Destruction of skin growth, 1-14 growths 69 66 $98
99213 Established patient office or other outpatient visit, 20-29 minutes 66 54 $88
17004 Destruction of precancer skin growth, 15 or more growths 53 51 $163
11103 Biopsy of related skin growth, each additional growth 52 34 $49

In context: peer comparison

Among 4 peers in Bradenton Dermatology Physician, average services per provider: 151. This provider delivers 12× the peer median.

Open Payments

Industry payments received

CMS Open Payments
All-time total
$129
Transactions
5
Manufacturers
2
Payer (manufacturer) Industry Txns Amount
Boehringer Ingelheim Pharmaceuticals, INC. 3 $84.03
Novartis Pharmaceuticals Corporation 2 $45.17

By nature of payment

Food and Beverage
$129

Medicare Part D · 2023

Top prescriptions

CMS Part D Prescriber
Total claims
199
Patients
139
Total drug cost
$5,871
Drug Type Claims Patients Total cost
Triamcinolone Acetonide Generic 47 38 $604
Ketoconazole Generic 46 35 $838
Hydrocortisone Generic 21 19 $125
Fluorouracil Generic 19 18 $1,939
Doxycycline Hyclate Generic 18 17 $799
Imiquimod Generic 13 12 $509
Doxycycline Monohydrate Generic 12 0 $255
Fluocinonide Generic 12 0 $615
Valacyclovir (Valacyclovir Hcl) Brand 11 0 $187

Frequently asked questions

Auto-generated from federal data
What is Dr. Erfon Ekhlasi's medical specialty?
Dr. Erfon Ekhlasi practices Dermatology Physician in Bradenton, FL.
Where does Dr. Erfon Ekhlasi practice?
Dr. Erfon Ekhlasi practices at 300 Riverside Dr E Ste 2200, Bradenton, FL 342081023. Office phone: 9417483376.
What is Dr. Erfon Ekhlasi's NPI?
Dr. Erfon Ekhlasi's National Provider Identifier (NPI) is 1013366582, issued by NPPES.
Does Dr. Erfon Ekhlasi accept Medicare assignment?
Yes. Dr. Erfon Ekhlasi accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Erfon Ekhlasi commonly perform?
Top Medicare-reported procedures in 2023: Destruction of precancer skin growth, 2-14 growths (HCPCS 17003); New patient office or other outpatient visit (HCPCS 99203); Destruction of precancer skin growth, 1 growth (HCPCS 17000). Source: CMS Medicare Physician & Other Practitioners file.